A Randomized, Safety, Tolerability and Pharmacokinetics 3-Period Crossover Study Comparing 2 Single Doses of ZTI-01 and Monurol in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 08 Oct 2017
Price : $35 *
At a glance
- Drugs Fosfomycin (Primary) ; Fosfomycin tromethamine
- Indications Pseudomonal infections
- Focus Adverse reactions; Pharmacokinetics
- 08 Oct 2017 Outcomes of population pharmacokinetic analysis (refinement) of ZTI-01 using pooled data from healthy subjects (NCT02178254) and patients (NCT02753946) with complicated urinary tract infections, presented at the IDWeek 2017.
- 05 Jun 2017 According to the Zavante Therapeutics media release, results from the study were be presented at the ASM Microbe 2017.
- 17 May 2017 According to the Zavante Therapeutics media release, data from the study will be presented at the ASM Microbe 2017.